(0)

ViroCyt

ViroCyt is the leader in the field of rapid virus quantification. Our goal is to provide the tools that deliver meaningful improvements to mission critical processes, such as vaccine manufacturing, protein expression, antiviral development and other settings where viruses play a significant role.

Upcoming Event!

 2015-04-16_10-29-52

Recent News

up
down
  • Military Group Uses ViroCyt Technology to Accelerate Ebola Research

    March 11, 8:30 ET Military Group Uses ViroCyt® Technology to Accelerate Ebola Research BOULDER, CO–(Marketwire – March, 2015) – ViroCyt, Inc., the leader in rapid virus quantification, announced today that the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) has published a scientific article in the journal Viruses titled “Evaluation of ViroCyt® Virus Counter®  Continue Reading »

    Read More arrow
  • ViroCyt Wins Colorado BioScience Association’s “Rising Star” Award

    BOULDER, CO–(Marketwire – November, 2014) – ViroCyt, LLC, the leader in rapid virus quantification, announced today that it has received the “Rising Star” award from the Colorado Bioscience Association after being nominated as one of three companies in the category. “The Colorado BioScience Association’s Rising Star award recognizes early stage growth companies that have made great  Continue Reading »

    Read More arrow
  • ViroCyt and I&L Biosystems Launch Virus Counter® 3100 at the World Vaccine Congress in Brussels

    BOULDER, CO–(Marketwire – October, 2014) – ViroCyt, LLC, the leader in rapid virus quantification, announced today that, in partnership with I&L Biosystems GmbH, it is formally launching the Virus Counter® 3100 in Europe at the World Vaccine Congress to be held October 13-15 in Brussels, Belgium. “The Virus Counter 3100 is the marquee analytical tool for  Continue Reading »

    Read More arrow
  • United States Department of Commerce Partners With ViroCyt to Expand Asian Markets

    BOULDER, CO–(Marketwired – Aug 27, 2014) – ViroCyt, LLC, the leader in rapid virus quantification, announced today that it is working with the US Department of Commerce’s Export Assistance Center In Denver to increase awareness of how the cutting edge Virus Counter system can be used to dramatically accelerate the creation of life-saving products. According to  Continue Reading »

    Read More arrow
  • United States Government-Supported Ebola Research Consortium Utilizes ViroCyt’s Technology for Rapid Virus Quantification

    BOULDER, CO–(Marketwire – August, 2014) – ViroCyt, LLC, the leader in rapid virus quantification, announced today that its breakthrough Virus Counter instrument is being used by a group of laboratories to develop filovirus medical countermeasures.  The Filovirus Animal Nonclinical Group or “FANG” is a US interdepartmental and interagency group established to support and facilitate the creation  Continue Reading »

    Read More arrow

Upcoming Events


May
13

American Society of Gene and Cell Therapy Annual Meeting Event Details

Sep
28

ISBioTech 3rd Annual Fall Meeting Event Details

Oct
18

9th Vaccine and ISV Congress Event Details